# An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

> **NCT04646967** · PHASE2 · COMPLETED · sponsor: **Alberta Children's Hospital** · enrollment: 100 (actual)

## Conditions studied

- Pain, Postoperative
- Phimosis
- Paraphimosis
- Balanitis

## Interventions

- **DRUG:** Bupivacain
- **DRUG:** Sevoflurane
- **DRUG:** Acetaminophen
- **DRUG:** Ibuprofen
- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT04646967
- **Lead sponsor:** Alberta Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-25
- **Primary completion:** 2024-01-25
- **Final completion:** 2024-01-25
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04646967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04646967, "An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04646967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*